Health
Vaccine For Skin Cancer Shows Promise – HAPPI – happi.com
New information from phase 2 clinical trial.
A vaccine created to prevent the recurrence of the deadly skin cancer melanoma is about twice as effective when patients also receive two components that boost the number and effectiveness of immune system cells called dendritic cells, according to phase 2 clinical trial results published in Nature Cancer in November.
These results are important, according to researchers, because most cancer vaccine trials have failed to show clinical efficacy. These results show that adding two immune-boosting…
-
Business5 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Business9 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General24 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
Noosa News23 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment